在日常实践中解决犬类强化症的临床见解
Antonella Colella1, Dora Buonfrate2, Federica Lo Tempio1
1University of Bari, Department of Precision and Regenerative Medicine and Ionian Area, Section of Veterinary Clinics and Animal Production, S.p. Valenzano-Casamassima Km 3, 70010, Valenzano, (BA), Italy.
Topics in companion animal medicine
|January 6, 2024
概括
由于Strongyloides stercoralis引起的犬类强化症是欧洲新兴的寄生虫疾病. 早期诊断对狗至关重要,胃肠道症状和特定的超声波发现有助于检测.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 寄生虫学的寄生虫学
- 动物传播疾病 动物传播疾病
背景情况:
- 由于Strongyloides stercoralis引起的犬类强化症是欧洲的一个新兴的寄生虫疾病.
- 它是兽医临床的挑战和公共卫生的担忧,因为其动物感染的潜力.
- 鉴于狗狗可能出现严重的临床症状,早期诊断和治疗是理想的.
研究的目的:
- 追溯调查自然感染Strongyloides stercoralis的狗的临床和临床前发现.
- 专门分析与犬类强化症相关的胃肠道超声波变化.
- 为了确定这个新兴的寄生虫疾病的关键诊断指标.
主要方法:
- 对12只自然感染Strongyloides stercoralis的狗进行了回顾性研究.
- 通过体样本中的幼虫形态和聚合酶链反应 (PCR) 证实了诊断.
- 分析了临床,准临床和胃肠道超声波的发现.
主要成果:
- 胃肠道症状,主要是腹和减肥,是最常见的投诉.
- 常见的发现包括低蛋白质血,贫血,白细胞症和改变的α2-全球蛋白水平.
- 超声波揭示了一个膨胀的,无的小肠与改变的壁层作为最常见的发现.
结论:
- 胃肠道超声波的变化,以及临床和准临床数据,可以增加对犬类强化症的怀疑.
- 这些发现可能有助于将强化症纳入腹的狗的差异诊断.
- 来自全厚活检的组织病理学证实了寄生虫的存在,与内镜活检不同.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Inflammatory Bowel Disease IV: Pharmacological Management
128
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
128
Inflammatory Bowel Disease V: Surgical Management
147
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
147
Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
Chronic Bowel Disorders: Introduction
455
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
455
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
120
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
120


